Back
Speaker illustration

undefined undefined undefined

Presentations

Incidence and prognostic potential of elevated biomarkers of stress and remodelling at one year after primary percutaneous coronary intervention

Event: Heart Failure 2021

Topic: Biomarkers

Session: ePoster session

Access
Like
Thumbnail

Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access
Like
Thumbnail

Changing trends in heart failure hospitalizations 2010-2015 for patients with HFpEF and HFrEF

Event: HEART FAILURE 2016

Topic: Population studies / Epidemiology

Session: Population studies / Epidemiology

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources